The forecast for malignant neoplasms mortality in Brazil shows a steady increase in the standardized rate from 178.4 deaths per hundred thousand in 2024 to 179.9 in 2028. Since 2023 marks the baseline year for this upward trend, a careful analysis indicates a consistent year-on-year rise of roughly 0.22%. Over the five-year forecast, the average compound annual growth rate (CAGR) hovers around 0.21%, reflecting gradual but persistent growth in mortality rates.

Future trends to watch for include:

Advancements in medical technology and treatments, which could potentially alter the current mortality trajectory.
Government health policies and public awareness campaigns influencing cancer prevention and early detection strategies.
Socio-economic factors and changes in healthcare access which might impact mortality rates.